| 256.66 6.27 (2.5%) | 12-10 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 310.33 |
1-year : | 362.47 |
| Resists | First : | 265.7 |
Second : | 310.33 |
| Pivot price | 243.57 |
|||
| Supports | First : | 238.38 |
Second : | 221.5 |
| MAs | MA(5) : | 254.86  |
MA(20) : | 241.8 |
| MA(100) : | 267 |
MA(250) : | 0 | |
| MACD | MACD : | -1.3 |
Signal : | -4.7 |
| %K %D | K(14,3) : | 78 |
D(3) : | 80.5 |
| RSI | RSI(14): 54 |
|||
| 52-week | High : | 315.35 | Low : | 206.86 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ HUM ] has closed below upper band by 21.7%. Bollinger Bands are 12.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 257.2 - 258.64 | 258.64 - 259.96 |
| Low: | 243.98 - 245.85 | 245.85 - 247.56 |
| Close: | 253.9 - 256.66 | 256.66 - 259.19 |
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Wed, 10 Dec 2025
Humana Healthy Horizons in Oklahoma (NYSE: HUM) funds six nonprofits with $295,500 - Stock Titan
Wed, 10 Dec 2025
Federated Hermes Inc. Acquires 57,680 Shares of Humana Inc. $HUM - MarketBeat
Wed, 10 Dec 2025
Ardsley Advisory Partners LP Acquires Shares of 50,000 Humana Inc. $HUM - MarketBeat
Tue, 09 Dec 2025
How is Humana stock performance compared to other healthcare services stocks? - MSN
Tue, 09 Dec 2025
Bank of Nova Scotia Acquires 166,475 Shares of Humana Inc. $HUM - MarketBeat
Fri, 05 Dec 2025
Jefferies Upgrades Humana (HUM) - Nasdaq
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Plans
|
|
| Shares Out | 120 (M) |
| Shares Float | 120 (M) |
| Held by Insiders | 0.2 (%) |
| Held by Institutions | 97.6 (%) |
| Shares Short | 4,240 (K) |
| Shares Short P.Month | 3,970 (K) |
| EPS | 10.68 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 154 |
| Profit Margin | 1 % |
| Operating Margin | 2 % |
| Return on Assets (ttm) | 4.5 % |
| Return on Equity (ttm) | 7.1 % |
| Qtrly Rev. Growth | 11.1 % |
| Gross Profit (p.s.) | 157.06 |
| Sales Per Share | 1050.63 |
| EBITDA (p.s.) | 32.09 |
| Qtrly Earnings Growth | -59.3 % |
| Operating Cash Flow | 2,040 (M) |
| Levered Free Cash Flow | 1,580 (M) |
| PE Ratio | 24 |
| PEG Ratio | 0 |
| Price to Book value | 1.66 |
| Price to Sales | 0.24 |
| Price to Cash Flow | 15.13 |
| Dividend | 0.87 |
| Forward Dividend | 0 |
| Dividend Yield | 0.3% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|